- Home
- DHAI vs PLUR Comparison
DHAI vs PLUR Comparison
Compare DHAI & PLUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DHAI
- PLUR
- Stock Information
- Founded
- DHAI 2007
- PLUR 2001
- Country
- DHAI United States
- PLUR Israel
- Employees
- DHAI N/A
- PLUR N/A
- Industry
- DHAI
- PLUR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DHAI
- PLUR Health Care
- Exchange
- DHAI NYSE
- PLUR Nasdaq
- Market Cap
- DHAI 10.5M
- PLUR 41.9M
- IPO Year
- DHAI N/A
- PLUR N/A
- Fundamental
- Price
- DHAI $0.22
- PLUR $3.96
- Analyst Decision
- DHAI
- PLUR Strong Buy
- Analyst Count
- DHAI 0
- PLUR 1
- Target Price
- DHAI N/A
- PLUR $12.00
- AVG Volume (30 Days)
- DHAI 2.1M
- PLUR 17.1K
- Earning Date
- DHAI 07-14-2025
- PLUR 05-13-2025
- Dividend Yield
- DHAI N/A
- PLUR N/A
- EPS Growth
- DHAI N/A
- PLUR N/A
- EPS
- DHAI N/A
- PLUR N/A
- Revenue
- DHAI $69,573,000.00
- PLUR $1,034,000.00
- Revenue This Year
- DHAI N/A
- PLUR $472.39
- Revenue Next Year
- DHAI N/A
- PLUR $254.29
- P/E Ratio
- DHAI N/A
- PLUR N/A
- Revenue Growth
- DHAI 5.40
- PLUR 203.23
- 52 Week Low
- DHAI $0.12
- PLUR $3.33
- 52 Week High
- DHAI $3.67
- PLUR $7.13
- Technical
- Relative Strength Index (RSI)
- DHAI 48.38
- PLUR 37.09
- Support Level
- DHAI $0.20
- PLUR $4.04
- Resistance Level
- DHAI $0.26
- PLUR $4.50
- Average True Range (ATR)
- DHAI 0.04
- PLUR 0.40
- MACD
- DHAI -0.00
- PLUR -0.05
- Stochastic Oscillator
- DHAI 23.33
- PLUR 7.03
About DHAI DIH HOLDINGS US INC
DIH Holding US Inc is a provider of robotic devices used in physical rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions. Its products Armeo Power, Armeo Spring, Armeo Spring Pro, etc.
About PLUR Pluri Inc.
Pluri Inc is a biotechnology company, that creates cell-based products for commercial use and is pioneering a biotech revolution that promotes wellbeing and sustainability. The company's technology platform developed a three-dimensional, or 3D, technology platform for cell expansion with an industrial scale in-house Good Manufacturing Practice, or GMP, cell manufacturing facility. It uses its technology in the field of regenerative medicine, food tech and agricultural technology or agtech.